Related Experiment Videos
Composite resection of posterior pelvic malignancy.
H J Wanebo1, R J Koness, P S Turk
1Department of Surgery, Brown University, Providence, Rhode Island 02908.
Annals of Surgery
|June 1, 1992
Summary
Composite resection of advanced pelvic malignancies, including rectal, anorectal, cervical, bladder, chordoma, bone, and soft tissue tumors, offers a viable treatment option. This surgical approach demonstrated acceptable survival rates and functional recovery in a cohort of 76 patients.
Area of Science:
- Surgical Oncology
- Musculoskeletal Oncology
- Pelvic Reconstruction
Background:
- Advanced pelvic cancers present significant surgical challenges due to invasion of bony pelvis, adjacent viscera, and prior irradiation.
- Composite resection is a complex procedure for managing extensive pelvic malignancies.
Purpose of the Study:
- To evaluate the outcomes of composite resection for posterior or lateral pelvic malignancies.
- To assess survival rates and functional recovery following extensive pelvic tumor resections.
Main Methods:
- Retrospective analysis of 76 patients undergoing composite resection for pelvic malignancies.
- Inclusion of patients with secondary cancers (rectal, anorectal, cervical, bladder) and primary tumors (chordomas, bone, soft tissue).
- Surgical procedures involved major resection of the sacrum or pelvic side walls, with some requiring exenterative procedures.
Main Results:
- Overall mortality rate was 7.9%.
- Long-term survival rates: 24% for curative rectal cancer resection, 22.5% for advanced epidermoid cancer.
- 50% survival for primary bone/soft tissue tumors (13-88 months).
- Most patients achieved reasonable functional recovery and returned to previous lifestyles.
Conclusions:
- Composite resection is a feasible surgical strategy for advanced pelvic malignancies.
- The procedure offers potential for long-term survival and good functional outcomes in selected patients.
- Further research into optimizing surgical techniques and adjuvant therapies is warranted.